4 ms·
Cancer is solved: by PD-1/PDL-1 inhibitors
- nanofortnight 8y agoImproper title. 1. This is specifically about non-SCLC. 2. This article is entirely about a downside to receiving PD-1/PDL-1 inhibitor biologics as immunotherapy; that approximately a third of patients develop HPD and should be switched to salvage chemotherapy as soon as this is noted.